M
Mark J. Eisenberg
Researcher at McGill University
Publications - 185
Citations - 12122
Mark J. Eisenberg is an academic researcher from McGill University. The author has contributed to research in topics: Randomized controlled trial & Smoking cessation. The author has an hindex of 47, co-authored 185 publications receiving 10628 citations. Previous affiliations of Mark J. Eisenberg include McGill University Health Centre & Jewish General Hospital.
Papers
More filters
Journal ArticleDOI
The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.
Salvatore Mottillo,Kristian B. Filion,Jacques Genest,Lawrence Joseph,Louise Pilote,Paul Poirier,Stéphane Rinfret,Ernesto L. Schiffrin,Mark J. Eisenberg +8 more
TL;DR: A systematic review and meta-analysis of the cardiovascular risk associated with the metabolic syndrome as defined by the 2001 NCEP and 2004 revised National Cholesterol Education Program definitions found the syndrome is associated with a 2-fold increase in cardiovascular outcomes and a 1.5- fold increase in all-cause mortality.
Journal ArticleDOI
Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery.
Jonathan Afilalo,Mark J. Eisenberg,Jean-Francois Morin,Howard Bergman,Howard Bergman,Johanne Monette,Johanne Monette,Nicolas Noiseux,Louis P. Perrault,Karen P. Alexander,Yves Langlois,Nandini Dendukuri,Patrick Chamoun,Georges Kasparian,Sophie Robichaud,S. Michael Gharacholou,J. F. Boivin +16 more
TL;DR: Gait speed is a simple and effective test that may identify a subset of vulnerable elderly patients at incrementally higher risk of mortality and major morbidity after cardiac surgery.
Journal ArticleDOI
Efficacy of exercise-based cardiac rehabilitation post–myocardial infarction: A systematic review and meta-analysis of randomized controlled trials
TL;DR: In this paper, a meta-analysis of randomized controlled trials (RCTs) was conducted to estimate the effect of exercise-based cardiac rehabilitation (CR) on cardiovascular outcomes and examine the impact of CR program characteristics on the magnitude of CR benefits.
Journal ArticleDOI
Role of frailty in patients with cardiovascular disease.
TL;DR: There exists a relation between frailty and CVD; frailty may lead to CVD, just as CVD may leadTo frailty, the presence of frailty confers an incremental increase in mortality.
Journal ArticleDOI
Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants ( Dabigatran , Rivaroxaban , Apixaban ) Versus Warfarin in Patients With Atrial Fibrillation
Corey S. Miller,Sonia M. Grandi,Avi Shimony,Avi Shimony,Avi Shimony,Kristian B. Filion,Mark J. Eisenberg,Mark J. Eisenberg +7 more
TL;DR: The new oral anticoagulants are more efficacious than warfarin for the prevention of stroke and systemic embolism in patients with AF and appear to have a favorable safety profile, making them promising alternatives towarfarin.